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Abstract
Background: Histone lysine methylation plays a fundamental role in chromatin organization and
marks distinct chromatin regions. In particular, trimethylation at lysine 9 of histone H3 (H3K9) and
at lysine 20 of histone H4 (H4K20) governed by the histone methyltransferases SUV39H1/2 and
SUV420H1/2 respectively, have emerged as a hallmark of pericentric heterochromatin. Controlled
chromatin organization is crucial for gene expression regulation and genome stability. Therefore,
it is essential to analyze mechanisms responsible for high order chromatin packing and in particular
the interplay between enzymes involved in histone modifications, such as histone
methyltransferases and proteins that recognize these epigenetic marks.
Results: To gain insights into the mechanisms of SUV420H2 recruitment at heterochromatin, we
applied a tandem affinity purification approach coupled to mass spectrometry. We identified
heterochromatin proteins HP1 as main interacting partners. The regions responsible for the
binding were mapped to the heterochromatic targeting module of SUV420H2 and HP1
chromoshadow domain. We studied the dynamic properties of SUV420H2 and the HP1 in living
cells using fluorescence recovery after photobleaching. Our results showed that HP1 proteins are
highly mobile with different dynamics during the cell cycle, whereas SUV420H2 remains strongly
bound to pericentric heterochromatin. An 88 amino-acids region of SUV420H2, the
heterochromatic targeting module, recapitulates both, HP1 binding and strong association to
heterochromatin.
Conclusion: FRAP experiments reveal that in contrast to HP1, SUV420H2 is strongly associated
to pericentric heterochromatin. Then, the fraction of SUV420H2 captured and characterized by
TAP/MS is a soluble fraction which may be in a stable association with HP1. Consequently,
SUV420H2 may be recruited to heterochromatin in association with HP1, and stably maintained at
its heterochromatin sites in an HP1-independent fashion.
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Background
Eukaryotic DNA is packaged within the nucleus through
its association with histone proteins forming the funda-
mental repeating unit of chromatin, the nucleosome. The
nucleosome consists of 146 bp of DNA wrapped around a
histone core octamer composed of two each of histones
H2A, H2B, H3, and H4 [1]. Histone C- and N-terminal
tails are flexible, protrude from the nucleosome octamer
structure, and are subjected to post-translational modifi-
cations, including acetylation, methylation, phosphoryla-
tion, ubiquitination or sumoylation. Among these
modifications, histone lysine methylation patterns have
been associated with distinct chromatin states and are
proposed to be major epigenetic marks that could extend
the information potential of the genetic code by fixing the
chromatin organization in a heritable manner (for a
review [2]).
In particular, constitutive heterochromatin, considered as
the part of the genome that is gene poor, transcriptionally
silent and highly condensed in interphase cells, is charac-
terized to harbour nucleosomes rich in trimethylation at
lysine 9 of histone H3 (H3K9me3), trimethylation at
lysine 20 of histone H4 (H4K20me3) and monomethyla-
tion at lysine 27 of histone H3 (H3K27me1) [3-5]. The
histone methyltransferases SUV39H1 and SUV39H2 play
a crucial role in the initial steps of heterochromatin for-
mation in mammals by selective trimethylation of H3K9
[3,6,7]. Indeed, mice that are deficient for SUV39H activ-
ities were shown to display impaired H3K9 trimethylation
at pericentric heterochromatin and were subjected to
chromosomal instability [8]. The molecular mechanisms
by which SUV39H1 and SUV39H2 are recruited at hetero-
chromatin are still unknown but were suggested to be
mediated by direct or indirect association with compo-
nents of a RNA interference pathway [9]. According to cur-
rent models, H3K9me3 marks placed by SUV39H
activities stabilize heterochromatin protein 1 (HP1) bind-
ing at heterochromatin [10,11], and HP1 proteins would
then recruit the histone methyltransferases SUV420H2
and SUV420H1 which in turn, trimethylate H4K20
[5,12,13]. At present, it is unclear whether SUV420H his-
tone methyltransferases interact only temporally with
chromatin to methylate H4K20 or participate in a more
stable multiprotein complex together with HP1 or other
chromatin proteins to support a stable heterochromatin
structure.
Interestingly, maintenance of stable heterochromatin
domains in living cells involves the transient binding and
dynamic exchange of HP1 from chromatin [14-16] indi-
cating that heterochromatin is not a static and inaccessible
higher order conformation but is a dynamic domain of
chromatin. In contrast to HP1, SUV39H1 has a signifi-
cantly slower exchange rate and a substantial fraction
immobile at heterochromatin [17], and nothing is known
about the dynamics of the SUV420H class of histone
methyltransferases.
To gain further insights into the role that SUV420H2 plays
in heterochromatin, we first used a directed proteomic
analysis of SUV420H2-binding proteins in cells using the
tandem affinity purification (TAP)-mass spectrometry
(MS) methodology [18]. We showed that HP1 proteins
are the main SUV420H2 interacting partners. We then
investigated the in vivo kinetics of SUV420H2 in mouse
L929 cells and compared them to those of HP1 proteins.
Using fluorescence recovery after photobleaching (FRAP)
analysis we showed that in contrast to HP1 proteins,
SUV420H2 has a slow exchange rate and is largely
strongly bound at pericentric heterochromatin. Further-
more, we mapped the domain responsible for stable asso-
ciation to chromatin to a region of 88 amino-acids of
SUV420H2, previously defined as the heterochromatic
targeting module by Schotta et al. [5].
Results and discussion
SUV420H2 interacts with HP1 proteins
Pericentric regions, as well as telomeres, are part of the
constitutive heterochromatin, which is characterized by
hypermethylation of DNA, hypoacetylation and hyper-
methylation of histones. In particular, trimethylation of
H3K9 (H3K9me3) and trimethylation of H4K20
(H4K20me3) by the SUV39H and SUV420H histone
methyltransferases respectively, mark pericentric chroma-
tin [3-5,19]. In order to gain insight into the mechanisms
involved in the recruitment of SUV420H enzymes at het-
erochromatin and identify their interacting partners, we
applied the tandem affinity purification (TAP) technology
coupled to tandem mass spectrometry (MS/MS), since
this approach has proven to efficiently allow the charac-
terization of protein complexes from different cells in cul-
ture or organisms [20]. TAP/MS analysis of protein
associations around SUV420H2 was performed from
HeLa cells, because we have assembled a database of more
than 30 TAP/MS experiments from proteins involved in
chromatin regulation in this cell line. This dataset allows
reliable assessment of a given interaction (data not
shown).
A retrovirus gene transfer strategy was used to generate a
cell pool expressing TAP-tagged SUV420H2 fusion pro-
tein. Expanded cell pools were subjected to tandem affin-
ity purification, a procedure consisting of two specific
binding and two specific elution steps under mild condi-
tions, which preserve the integrity of non-transient pro-
tein-protein interactions [18]. The affinity purified
complexes were resolved on SDS-PAGE and Coomassie
stained (Fig. 1A). Then, proteins were identified by pep-
tide sequence determination using tandem mass spec-BMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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trometry (LC-MS/MS). Most proteins were characterized
by the identification of several peptides [see Additional
files 1 and 2]. Details on protein identification procedures
are given in the Methods section. The tagged SUV420H2
protein represents a prominent band on the gel and was
identified by peptides covering 36% of its total sequence
(Fig. 1B). However, SUV420H2 was not the most abun-
dant protein recovered by TAP/MS since tubulin, which is
considered as a TAP/MS contaminant, remains the most
prominent identified protein. This relative low recovery of
SUV420H2 by TAP is probably due to its strong associa-
tion to chromatin (see below). Sonication or addition of
intercalating agents such as ethidium bromide [21], prior
to protein extraction, did not improve the recovery rate of
SUV420H2 by TAP/MS (data not shown). In spite of a
weak recovery of the bait, heterochromatin proteins (HP)
1 were identified as specific SUV420H2 interactors (Fig.
1A) by identified peptides covering 53% (HP1γ – CBX3)
and 15% (HP1α – CBX5) of their total sequence, respec-
tively. The third member of the HP1 protein family, HP1β
Identification of SUV420H2 associated proteins using TAP/MS Figure 1
Identification of SUV420H2 associated proteins using TAP/MS. (A) TAP-SUV420H2 purification from HeLa cells. 
TAP-SUV420H2 protein complexes were purified from HeLa cells, separated by SDS-PAGE, and stained with colloidal 
Coomassie. Some of the co-purified proteins identified by LC-MS/MS are indicated. (B) SUV420H2 peptide coverage is 36%. 
The identified peptides are indicated in red bold on the SUV420H2 protein sequence. Peptides are dispersed over the full 
sequence of the protein. (C) Western blotting showing the presence of HP1β in the TAP-SUV420H2 purification. Total pro-
tein extracted from HeLa cells expressing TAP-SUV420H2 (Whole lysate; 50 μg of proteins) and TAP purified sample (CBP 
Eluate; 20% of the material used for MS identification) were separated by SDS-PAGE and proteins detected by Western blot-
ting using specific antibodies. Tagged SUV420H2 was revealed using an anti-CBP antibody (α-CBP), while HP1β was revealed 
by an anti-HP1β antibody (α-HP1β). Note that the TEV protease-mediated cleavage of the Protein A moiety of the TAP tag 
during the purification procedure increases the gel mobility of the tagged SUV420H2 protein in the CBP eluate as compared to 
whole extract.
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(CBX1) was not formally identified in the purification.
However, the peptide IIGATDSSGELMFLMK identified in
the SUV420H2 purification, is common to HP1γ and
HP1β sequences. Moreover, HP1β was identified by West-
ern blotting using specific anti-HP1β antibodies in the
TAP-SUV420H2 purified samples (Fig. 1C). Conse-
quently, an interaction between SUV420H2 and HP1β
might occur as well. None of the other proteins identified
by TAP/MS appeared to be specific to the SUV420H2 puri-
fication when compared to our dataset. Thus, we conclude
that SUV420H2 mainly interacts with the HP1 isotypes in
vivo; HP1α, HP1γ and HP1β as well.
Shotta et al [5] mapped a HP1-binding domain of murine
Suv420h2 in the AA349–441 protein region referred as
the heterochromatic targeting module, once this domain
is also responsible for Suv420h2 targeting at heterochro-
matin. To confirm that such a functional module is also
conserved in the human ortholog, the corresponding
region (AA347–435) from human SUV420H2 was
expressed in E. coli as a recombinant GST fusion protein
and bound to glutathione-Sepharose beads. Full-length
TAP-tagged HP1α, HP1β and HP1γ were expressed in
HEK293 cells and incubated with GST-SUV420H2 [347–
435] fragments. After extensive washings, bound proteins
were eluted with glutathione, separated on SDS-PAGE and
Western blots were probed with peroxydase coupled anti-
peroxydase antibody for detection of TAP-tagged HP1 iso-
types. Figure 2A shows that the SUV420H2 [347–435]
fragment interacts with all three HP1 proteins. In contrast,
recombinant GST-GFP fusion protein does not interact
with HP1, excluding unspecific binding to the GST-tag.
Thus, the heterochromatic targeting module from human
SUV420H2, as previously described for its mouse counter-
part [5], interacts with all three HP1 isotypes, HP1α,
HP1β and HP1γ . Interestingly, this domain of SUV420H2
contains a PYVRV sequence, which is similar to the penta-
meric sequences found through a phage display analysis
with the Drosophila melanogaster HP1 chromoshadow
domain [22] and present in a number of proteins interact-
ing to mammalian HP1 chromoshadow domains [23].
To define the HP1 regions involved in the binding to
SUV420H2, TAP-tagged mutants of HP1γ were transiently
expressed in HEK293 cells. Nuclear protein extracts were
incubated with the recombinant GST-SUV420H2 [347–
435] heterochromatic targeting module (Fig. 2B). Dele-
tion of HP1γ chromoshadow domain (CSD) abolishes
HP1γ dimerization as expected [24-26], but also the inter-
action with the SUV420H2 [347–435] fragment, whereas
deletion of lysine 105 to lysine 107 within the HP1γ hinge
region does not affect binding to the SUV420H2 hetero-
chromatic targeting module. Thus, the HP1 CSD is
required for SUV420H2-HP1 interaction. In order to test
whether the HP1 CSD is sufficient for such an interaction,
a GST-CSD fusion protein was expressed in E. coli, bound
to glutathione-Sepharose and incubated with in vitro
translated TAP-SUV420H2 [347–435] or TAP-GFP pro-
teins. Figure 2C shows that the SUV420H2 [347–435]
fragment specifically interacts with GST-CSD, but not
GST-GFP. Taken all together, these results indicate that the
interaction between SUV420H2 and HP1 proteins is
mediated by the binding of the heterochromatic targeting
module to the chromoshadow domain of the respective
proteins.
HP1 is a dynamic component of heterochromatin and its 
dynamics depend on the cell cycle
To assay for protein dynamics at heterochromatin, fluo-
rescence recovery after photobleaching (FRAP) [27] exper-
iments were performed in live murine L929 cells. These
cells were used in our imaging analyses, because mouse
fibroblastic cells present a defined distribution of hetero-
chromatic domains revealed by Hoechst staining patterns
as bright fluorescent nuclear regions (Fig. 3A).
GFP-HP1 expressing cells were generated using retroviral
gene transduction. Fusion proteins of GFP with HP1α,
HP1β and HP1γ were shown to localize to these hetero-
chromatin foci (Fig. 3A). The endogenous HP1 counter-
parts were shown to be localized at the same nuclear
domains, as revealed by immunochemistry using specific
anti-HP1 antibodies ([28] and data not shown). Expres-
sion of GFP-HP1 fusion proteins was analyzed by Western
blotting using specific antibodies for each HP1 isotype
(Fig. 3B). GFP-HP1 fusion proteins were expressed as full-
length proteins at levels significantly higher (GFP-HP1β)
or similar (GFP-HP1γ and GFP-HP1α) to those of their
endogenous counterparts.
Defined areas of ~1.3 μm of diameter were irreversibly
photobleached by five excitation pulses of 336 ms. Fluo-
rescence recovery in the same areas was imaged at regular
time intervals (Fig. 3C and see Methods section). The rel-
ative fluorescence intensity values for each experiment
were collected and plotted in a FRAP curve after correction
for photobleaching. The t1/2 value of fluorescence recov-
ery, which is a measure for the speed of replacement of
molecules in the bleached area by molecules from the
environment was determined, as well as the intensity of
fluorescence recovery after 30 s, which is a measure of the
mobile fraction of molecules (Fig. 3D and 3E). As previ-
ously reported by others in other cell types [14-16,29],
Figure 3C–D shows that HP1 proteins are highly dynamic
components of heterochromatin in L929 cells. The high
mobility of ectopically expressed GFP-HP1 proteins might
not be a consequence of protein overexpression since sim-
ilar observations have been obtained in different experi-
mental settings [14-16,29]. For instances, Schmiedeberg
et al [16] determined similar t1/2 values from Hep-2 cellsBMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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Identification of SUV420H2 and HP1 interacting domains by in vitro GST-pull down Figure 2
Identification of SUV420H2 and HP1 interacting domains by in vitro GST-pull down. (A) The heterochromatic tar-
geting module of SUV420H2 interacts with HP1 proteins. GST-tagged truncation SUV420H2 [347–435], as well as control 
GST-GFP fusion were bound to glutathione-Sepharose and incubated with nuclear extracts from HEK293 cells expressing 
TAP-tagged HP1α, HP1β, or HP1γ as indicated. After extensive washings, proteins were separated on SDS-PAGE and Western 
blot probed to reveal TAP-tagged proteins. (B) The chromoshadow domain of HP1γ is required for its interaction with 
SUV420H2. GST-SUV420H2 [347–435], as well as control GST-HP1γ fusions were bound to glutathione-Sepharose and incu-
bated with nuclear extracts from HEK293 cells expressing TAP-HP1γ truncations or TAP-GFP control. HP1γ [ΔKKK] har-
bours a deletion from lysine 105 to lysine 107 within the hinge region, whereas HP1γ [ΔCSD] contains the 114 N-terminus 
amino-acids of HP1γ but not the chromoshadow domain. Loss of the chromoshadow domain abolishes the interaction with the 
heterochromatic targeting module of SUV420H2 and HP1γ oligomerization. (C) The chromoshadow domain (CSD) of HP1γ 
interacts with the SUV420H2 [347–435] region. GST-HP1γ [CSD] consisting of the HP1γ chromoshadow domain (AA 115–
183), as well as control GST-HP1γ and GST-GFP fusions were bound to glutathione-Sepharose and incubated with in vitro 
translated TAP-SUV420H2 [347–435] fusion protein or TAP-GFP control. Bound TAP-tagged proteins are revealed by West-
ern blotting using the peroxidase-anti-peroxidase (PAP) antibody (Sigma) which recognizes the protein A moiety of the TAP 
tag.
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expressing GFP-HP1 proteins at levels lower than those of
their endogenous counterparts. It indicates that HP1
dynamic parameters do not depend on the GFP-HP1
expression levels. However, we observed that for each of
the three GFP-HP1 isotypes, t1/2 values from one photob-
leached cell to another show a significantly high variabil-
ity (Fig. 3E).
In order to test whether this large distribution of t1/2 val-
ues could reflect different states of the cells, we performed
FRAP experiments after cell synchronization (Fig. 4). GFP-
HP1 expressing cells were blocked in G0 by serum starva-
tion for 72 hours, or in G2/M transition using a nocoda-
zole treatment for 24 hours [30]. Cell synchronization
was verified by fluorescent-activated cell sorter (FACS)
analysis in presence of propidium iodide [31], and FRAP
performed. Figure 4A–B shows that, in all cases, cell syn-
chronization reduces the variability of the t1/2 values.
After serum deprivation, the t1/2 was ~11.3 s, ~9.4 s, and
11.2 s for HP1α, HP1β and HP1γ, respectively, but only
~7.4 s, ~6.8 s, and ~7.1 s after the nocodazole treatment.
Both serum starvation and nocodazole treatment did not
affect GFP-HP1 protein localization (Fig. 4A–B) or pro-
tein expression (Fig. 4C). This suggests that HP1 proteins
at heterochromatin have faster dynamics in G2 rather
than in G0 phase of the cell cycle.
In order to demonstrate that these differences in HP1
dynamics were due to intrinsic properties of HP1 but not
a consequence of the treatments, similar experiments
were performed with NSD3S, another protein associated
to heterochromatin. Based on alternative splicing events,
the NSD3 gene encodes two different proteins [32]: a long
isoform (NSD3L) related to the histone methyltransferase
Nsd1, and a short isoform (NSD3S) which does not con-
tain the SET domain and the PHD fingers, but still har-
bouring a PWWP motif. NSD3S was stably expressed as a
GFP fusion protein in L929 cells using retroviral transduc-
tion. Figure 5A shows that NSD3S is targeted at pericentric
heterochromatin. FRAP experiments revealed that NSD3S
is as dynamic as HP1 at heterochromatin (Fig. 5B–C).
GFP-NSD3S fluorescence recovery reached ~80% after 30
s with a t1/2 value ~8.4 s. These dynamic parameters are
similar to those of HP1 proteins (Fig. 3D), indicating that
HP1 proteins are not the only mobile components associ-
ated to heterochromatin with such a highly dynamic
exchange rate. Next, FRAP experiments after cell synchro-
nization were performed on GFP-NSD3S expressing L929
cells. Figure 5D–E shows that t1/2 values are relatively
similar after serum starvation and nocodazole treatment.
This result indicates that the treatments used to induce cell
synchronization do not modify significantly NSD3S
dynamics at heterochromatin. Consequently, the differ-
ences of mobility in HP1 protein dynamics during the cell
cycle are indeed due to their intrinsic properties, but not
to culture conditions.
SUV420H2 is a stable component of heterochromatin
To gain insights into the dynamic properties of
SUV420H2 and its association to heterochromatin, FRAP
experiments were performed on L929 stably expressing a
GFP-SUV420H2 fusion protein (Fig. 6C–D). In contrast to
HP1 proteins, GFP-SUV420H2 fluorescence recovery
reached only 10% as a maximum after 60 s, suggesting
that ~90% of the SUV420H2 fraction is stably bound
within heterochromatic domains. Even after several min-
utes, the intensity of fluorescence recovery remains weak
(see below, Figure 7). Together, these results indicate that
SUV420H2 is more stably associated to heterochromatin
than HP1 proteins. This suggests that in addition to its
function as a histone methyltransferase, SUV420H2
might have a structural role in chromatin organization.
To identify the protein domains involved in stable associ-
ation of SUV420H2 at heterochromatin, we stably
expressed various protein deletions as GFP fusions in
L929 cells. Figure 6A shows a schematic representation of
the protein truncations used. Consistent with previous
data [5], the N-terminus of SUV420H2 comprising the
catalytically active SET domain is dispersed within the
nucleus, whereas the C-terminal part of the protein is
associated with heterochromatin that corresponds to
Hoechst dense staining (Fig. 6B). Moreover, the 88
amino-acids region comprising the heterochromatic tar-
geting module of SUV420H2 is sufficient to recapitulate
full length protein localization. Next, FRAP studies were
performed in L929 cells expressing SUV420H2 C-termini-
GFP fusion proteins still located at heterochromatin foci.
The C-terminal truncation as well as the heterochromatic
targeting module alone, show kinetic properties similar to
those of SUV420H2 full length (Fig. 6C–D). At the oppo-
site, the SUV420H2 [1–280] protein region comprising
the SET domain, is highly mobile. Thus, in contrast to
SUV39H1 for which the SET domain has been shown to
contribute to heterochromatin binding [17], all the
dynamic characteristics of SUV420H2 are restricted to the
88 amino-acids heterochromatic targeting module.
So far, the mechanism by which the heterochromatic tar-
geting module is tightly bound to chromatin remains elu-
sive. Using a GST-pull down-mass spectrometry strategy,
the only proteins found to interact in vitro with this
domain were the HP1 proteins (data not shown), but
other approaches are ongoing to unravel the molecular
mechanisms involved in the linkage of SUV420H2 to het-
erochromatin.
Next, we compared the SUV420H2 kinetics with the one
of H2AFY. H2AFY (macroH2A1) is a variant of histone
H2A, enriched at the inactive X chromosome in female
mammals and found at other chromosomal locations
[33]. Since H2AFY is more resistant to salt extraction than
canonical H2A [34], it is expected that H2AFY might be inBMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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FRAP analysis of GFP-HP1 shows that HP1 proteins are dynamic components of heterochromatin Figure 3
FRAP analysis of GFP-HP1 shows that HP1 proteins are dynamic components of heterochromatin. (A) Nuclear 
localization of GFP-tagged proteins. GFP-HP1 expressing L929 cells were fixed with paraformaldehyde and localization of 
fusion protein was visualized with fluorescence microscopy. Dense foci seen by Hoechst staining represent pericentric hetero-
chromatin regions. (B) Detection of GFP-HP1 and endogenous HP1 isoforms in stable cell lines and in L929 cells by Western 
blotting using specific antibodies for each isoform (α-HP1β, α-HP1γ and α-HP1α). (C) Time-lapse series of confocal images of 
living cells expressing GFP-HP1β, GFP-HP1γ or GFP-HP1α, as indicated. Heterochromatic foci were selected and photob-
leached. Images were recorded before (Prebleach) and at different time intervals after the bleach. Arrows indicate the photob-
leached areas. (B) Parameters of HP1 protein dynamics from FRAP curves. The half-time of fluorescence recovery (t1/2), the 
percentage of fluorescence recovery after 30 s, and the number of FRAP curves used are indicated. (E) Representation of the 
number of cells characterized by a given t1/2 value. A single area was photobleached per cell.BMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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more stable association with H3-H4 and/or DNA than
H2A. H2AFY was stably expressed as a GFP fusion protein
in L929 cells using retroviral transduction. Figure 7A
shows that H2AFY is targeted at foci identified by Hoechst
staining as pericentric heterochromatin regions, like
SUV420H2. FRAP experiments performed over more than
30 min showed that fluorescence recovery after 20 min is
~22% and ~7% for GFP-SUV420H2 and GFP-H2AFY,
respectively (Fig. 7B–C). Thus, SUV420H2 is stably bound
to heterochromatin, but not as strongly as the nucleo-
some component, H2AFY.
Conclusion
The SUV420H family of histone methyltransferases cata-
lyzes trimethylation of histone H4K20 which is character-
istic to pericentric heterochromatin. So far, little is known
about the mechanisms by which this protein class is
recruited to and interacts with chromatin.
Here, we applied the TAP/MS approach in order to iden-
tify proteins associated to the histone methyltransfase
SUV420H2. In our purification, a relatively weak amount
of SUV420H2 was recovered, presumably because the
protein is tightly bound to chromatin. We assume that the
SUV420H2 captured by TAP mainly correspond to the
nucleoplasm soluble fraction. Most of the proteins identi-
fied by TAP/MS appeared to be nonspecific and recovered
in a number of unrelated purifications (data not shown).
However, members of the HP1 family were found as spe-
cific SUV420H2-binding partners. Since only part of the
SUV420H2 population was purified, we cannot exclude
that a number of SUV420H2 interacting partners, and in
particular the proteins associated to the SUV420H2 frac-
tion the most tightly bound to chromatin, were not iden-
tified.
We used in vitro GST-pull down assays, to map the
domains of interaction between SUV420H2 and HP1 pro-
teins. As previously described for the mouse Suv420h2
ortholog [5], an 88 amino-acids region defined as the het-
erochromatic targeting module of SUV420H2 interacts
with HP1α, HP1β and HP1γ proteins. Using deletion
mutants, the HP1 chromoshadow domain was shown to
be sufficient for binding to the SUV420H2 heterochro-
matic targeting module.
To investigate the mechanisms by which SUV420H2
could be recruited at heterochromatin and the possible
role of HP1 proteins in this recruitment, protein dynamics
were studied using fluorescence recovery after photob-
leaching (FRAP) in living cells [27]. For a long time, hete-
rochromatin was considered as a stable structure
maintained in an inaccessible conformation that would
exclude transcriptional activation. This concept has
changed when HP1 was shown by FRAP analysis to be
highly mobile [14,15]. In our study, we show that NSD3S
is another protein transiently bound to pericentric hetero-
chromatin, reinforcing the idea that the dynamic nature of
heterochromatin is essential to its function. Along our
study, we also showed that HP1 exchange kinetics is mod-
ified during the cell cycle, indicating that heterochromatin
organization is modulated during the cell cycle progres-
sion. However, not all the proteins bound to pericentric
heterochromatin are in continuous flux with the nucleo-
plasm since Krouels et al. showed that a substantial frac-
tion of the histone methyltransferase SUV39H1 is stably
associated with chromatin [17]. In this study, we demon-
strated that the major part of SUV420H2 is also tightly
bound at pericentric heterochromatin, indicating that in
addition to its histone methyltransferase activity,
SUV420H2 might have a structural role in chromatin
organization. We showed that the heterochromatic target-
ing module is sufficient to fully recapitulate SUV420H2
dynamic properties. Then, in contrast to SUV39H1 [17],
the SET domain of SUV420H2 is not required for stable
binding of the protein to pericentric heterochromatin.
Genetic studies indicated that H3K9 trimethylation would
precede H4K20 trimethylation, and that HP1 which rec-
ognizes H3K9 trimethylation could target SUV420H class
of histone methyltransferases to heterochromatin [5]. Our
data confirm such an interaction in vitro and in vivo.
However, FRAP experiments reveal that in contrast to
HP1, SUV420H2 is strongly associated to pericentric het-
erochromatin. Thus, the fraction of SUV420H2 captured
and characterized by TAP/MS is the soluble fraction which
may be in a stable association with HP1. Consequently,
we speculate that SUV420H2 is recruited to heterochro-
matin in association with HP1, but stably maintained at
its sites in an HP1-independent fashion.
Methods
Constructs and vectors engineering
Full-length open reading frames of all cDNAs, as well as
truncated and mutant cDNAs were PCR amplified from
IMAGE cDNA clones purchased from Deutsches Ressour-
cenzentrum für Genomforschung GmbH (RZPD) and
cloned into the GATEWAY entry vector pDONR201 (Inv-
itrogen).
Moloney murine leukemia virus-based vectors were gen-
erated from pLNCX2 (Clontech) in which an IRES-pac
cassette from pIRESpuro (Clontech) and conferring resist-
ance to puromycin was introduced. Then, GATEWAY
compatible target vectors for expression of TAP-tagged
(pRP-NTAP-GW) or GFP-tagged (pRP-NGFP-GW) pro-
teins were engineered by inserting GATEWAY and TAP
(from pZome-1-N, Cellzome) or GFP (from pEGFP-N1,
Clontech) cassettes, respectively. For bacterial expression
of the GST-tagged proteins, a GATEWAY cassette wasBMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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Dynamics of HP1 varies during cell cycle Figure 4
Dynamics of HP1 varies during cell cycle. Distribution of t1/2 values deduced from FRAP experiments for GFP-HP1β 
(upper panels), GFP-HP1γ (middle panels), and GFP-HP1α (lower panels) after serum starvation (A) or nocodazole treatment 
(B). The bars indicate the number of cells presenting a given t1/2 value. The effect of the treatments on cell synchronization is 
measured by FACS analysis (a-f). Nuclear localization of GFP-tagged HP1 proteins (G) and heterochromatin foci revealed by 
Hoechst staining (H) are shown. (C) Detection of GFP-HP1 and endogenous HP1 isoforms by Western blotting using specific 
antibodies for each isoform (α-HP1β, α-HP1γ and α-HP1α) in absence of treatment (Control), in presence of Nocodazole (50 
ng/ml) 24 hours or after 72 hours serum starvation.
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introduced into pGEX-4T1 (Amersham). Entry clones
were recombined into suitable target vectors by GATE-
WAY LR reactions. A list of clones used, primer and vector
sequences is available on request.
Cell culture and stable cell lines
HeLa (Human cervix epitheloid carcinoma – ECACC),
L929 (Mouse cell line C3H/An connective tissue –
ECACC) and HEK293 (ECACC) cell lines were main-
tained in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal bovine serum (Invitrogen),
100 U/ml penicillin (Invitrogen), and 100 μg/ml strepto-
mycin (Invitrogen) at 37°C in humidity-saturated 5%
CO2 atmosphere.
Retroviral stable cell lines were generated according to the
following procedure. Phoenix amphotropic packaging
cells (3 × 105 cells/well) were seeded in a 6-well plate and
transfected 24 hours later with 0.8 μg of retroviral plasmid
using Exgen 500 (Euromedex) following the instructions
of the manufacturer. After 48 hours virus-containing
supernatant was filtered through a 0.45-μm-pore-size fil-
FRAP analysis of GFP-NSD3S shows that NSD3S is a dynamic component of heterochromatin Figure 5
FRAP analysis of GFP-NSD3S shows that NSD3S is a dynamic component of heterochromatin. (A) Cellular 
localization of NSD3S. GFP-NSD3S expressing L929 cells were fixed with paraformaldehyde and localization of fusion protein 
was visualized with fluorescence microscopy. Dense foci seen by Hoechst staining represent pericentric heterochromatin 
regions (a). GFP-NSD3S labelling co-localizes at these sites (b). (B) Time-lapse serie of confocal images of living cells expressing 
GFP-NSD3S during a FRAP experiment. Images were recorded before (Prebleach) and at different time intervals after the 
bleach. Arrows indicate the photobleached areas. (C) Parameters of NSD3S protein dynamics derived from FRAP curves. The 
half-time of fluorescence recovery (t1/2), the percentage of fluorescence recovery after 30 s, and the number of FRAP curves 
used are indicated. (D) Representation of the number of cells characterized by a given t1/2 value after cell synchronization by 
serum starvation. (E) Representation of the number of cells characterized by a given t1/2 value after cell synchronization by 
nocodazole treatment.
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FRAP analysis of GFP-SUV420H2 shows that SUV420H2 is strongly associated to heterochromatin Figure 6
FRAP analysis of GFP-SUV420H2 shows that SUV420H2 is strongly associated to heterochromatin. (A) Sche-
matic representation of various SUV420H2 truncations used. The catalytically active SET domain is indicated. (B) Cellular local-
ization of SUV420H2 and the truncations expressed as GFP fusion proteins in L929 cells. Cells were fixed with 
paraformaldehyde and localization of fusion proteins was visualized with fluorescence microscopy. Dense foci seen by Hoechst 
staining represent pericentric heterochromatin regions (upper panels). GFP labelling is shown (lower panels). (C) Time-lapse 
series of confocal images of living cells expressing GFP-SUV420H2, GFP-SUV420H2 [1–280], GFP-SUV420H2 [281–462], and 
GFP-SUV420H2 [347–435] as indicated, during FRAP experiments. Images were recorded before (Prebleach) and at different 
time intervals after the bleach. Arrows indicate the photobleached areas. Relative fluorescence intensities are displayed in 
recovery curves (a-d). (D) Protein and truncations dynamics derived from FRAP curves. The percentage of fluorescence recov-
ery after 30 s, and the number of FRAP curves used are indicated.BMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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ter. HeLa or L929 cells (105 each) were seeded in a six-well
plate and transduced with 3 ml filtered virus supernatant
in the presence of 8 μg/ml of Polybrene for an infectious
round of 24 hours. Cells were then incubated for 24 hours
in normal medium. The polyclonal population of cells
was then selected with 1 μg/ml of puromycin. Growing
cells were then tested for recombinant protein expression
using immunocytochemistry for TAP-tagged protein
expression or immunofluorescence for GFP-tagged pro-
tein expression.
For cell cycle synchronization, cells were seeded at a con-
centration of 2 × 104 cells/cm2 either in 6-well plates or in
10-cm dishes and grown to 50–70% confluence to obtain
cultures in the logarithmic growth phase. Synchroniza-
tion in G0 was achieved by serum deprivation; cultures
were washed 3 times with PBS, once with DMEM and then
cultured for 72 hours in DMEM without serum, whereas
synchronization at G2/M transition was achieved using a
nocodazole treatment [30]; cultures were grown in
DMEM with 10% fetal bovine serum and 50 ng/ml noco-
dazole for 24 hours. All synchronization experiments
based on serum deprivation or nocodazole treatment
were performed in parallel to ensure accurate compari-
sons.
Antibodies and Western blotting
The following primary antibodies were used for Western
blotting: mouse anti-HP1α antibody (2HP-2G9, Eurome-
dex; used at a dilution of 1:2 000), mouse anti-HP1β anti-
body (1MOD-1A9, Euromedex; used at a dilution of 1:2
000), mouse anti-HP1γ antibody (2MOD-1G6, Eurome-
dex; used at a dilution of 1:2 000), goat anti-CBP antibody
(sc-9456, Santa Cruz Biotechnology; used at a dilution of
1:300). Secondary antibodies were: horseradish peroxi-
dase-congugated goat anti-mouse antibody (115-035-
003, Jackson ImmunoResearch; used at a dilution of 1:10
000), horseradish peroxidase-conjugated donkey anti-
goat antibody (705-035-003, Jackson ImmunoResearch;
used at a dilution of 1:5 000). The protein A moiety of the
TAP tag was revealed with rabbit peroxidase anti-peroxi-
dase antibody (P1291, Sigma; used at a dilution of 1:10
000).
For Western blotting, protein samples (50 μg) in SDS
loading buffer were electrophoresed on 4–12% Bis-Tris
gels (Invitrogen) and transferred to nitrocellulose mem-
branes (Schleicher & Schuell). The membranes were
blocked in 10% milk powder in PBS-T (1× PBS with 0.1%
Tween20) for 1 hour at room temperature, incubated for
same time with the primary antibody in PBS-T, and
washed three times 10 min in PBS-T. The membranes
were then incubated with the peroxidase-conjugated sec-
ondary antibody in PBS-T for 1 hour and afterward
washed three times 10 min in PBS-T. Signal was detected
using chemiluminescence reagent (ECL, Amersham) on
imaging film (GE Healthcare).
Flow cytometry
Cell cycle analysis was performed by flow cytometry as
described by Evans et al [31]. Single-cell suspensions were
obtained by trypsinization, washed twice with PBS and
incubated in 80% ethanol at room temperature for 16–24
hours. Cells were rinsed with PBS, resuspended in 200 μg/
ml Propidium Iodide (PI), incubated with 100 μg/ml
RNase at 37°C for 30 min, and stored at least one hour at
4°C. Stained cells were analyzed with a Coulter Epics XL
flow cytometer equipped with a 488-nm argon laser
(Beckman Coulter, Fullerton, CA) and a 530 nm band-
pass filter allowing detection of PI fluorescence. A mini-
mum of 10,000 events were collected. GFP or PI fluores-
cence was expressed as a ratio of the mean channel value
of the GFP or PI histogram to the mean channel value of
the isotype control histogram.
Tandem affinity purification
For Tandem affinity purification (TAP), cells expressing a
TAP-tagged protein were expanded into forty 15-cm
dishes. At confluence (about 100 mg total protein), cells
were harvested, washed with PBS, resuspended in cell lysis
buffer (10 mM Tris-HCl pH 7.4, 1.5 mM MgCl2, 10 mM
KCl, 25 mM NaF, 1 mM Na3VO4, 1 mM dithiothreitol
[DTT] and complete protease inhibitors [Roche]) and
homogenized by 20 strokes with a type B pestle. Nuclei
were recovered by centrifugation 10 min at 2000 g, resu-
pended in nuclear lysis buffer (50 mM Tris-HCl pH 7.4,
1.5 mM MgCl2, 420 mM NaCl, 20% glycerol, 25 mM NaF,
1 mM Na3VO4, 1 mM dithiothreitol [DTT] and complete
protease inhibitors [Roche]), and then incubated for 1
hour in a rotation wheel at 4°C to extract nuclear pro-
teins. Lysates were subsequently clarified by ultracentrifu-
gation at 100,000 g, 1 hour.
Nuclear lysate was incubated with IgG agarose beads
(Sigma) for 2 hours at 4°C in a rotation wheel. Bound
proteins were washed with an excess of lysis buffer and
then with a TEV-protease cleavage buffer (10 mM Tris-HCl
pH 7.5, 100 mM NaCl and 0.2% NP-40) and eluted by
addition of 30 mg TEV protease (Invitrogen) for 2 hours
at 16°C. The TEV-protease cleavage product was incu-
bated with calmodulin sepharose (Amersham) in the
presence of 2 mM CaCl2 for 30 min at 4°C in a rotation
wheel. After extensive washes in 100 mM Trs-HCl pH8,
100 mM NaCl, 0.5 mM EDTA, 2 mM CaCl2, calmodulin-
bound proteins were eluted by boiling in SDS loading
buffer.
Mass spectrometric analysis
Protein eluate was separated on a 4–12% NuPAGE Novex
gel (Invitrogen) and stained with Imperial Protein StainBMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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Comparison of SUV420H2 and H2AFY dynamics by FRAP Figure 7
Comparison of SUV420H2 and H2AFY dynamics by FRAP. (A) Cellular localization of GFP-H2AFY fusion proteins 
stably expressed in L929 cells. Cells were fixed with paraformaldehyde and localization of fusion proteins was visualized with 
fluorescence microscopy. GFP-H2AFY fusion proteins colocalize with dense foci identified by Hoechst staining as pericentric 
heterochromatin regions. (B) Time-lapse series of confocal images of living cells expressing GFP-SUV420H2 and GFP-H2AFY 
as indicated, during FRAP experiments. Images were recorded before (Prebleach) and at different time intervals after the 
bleach. Arrows indicate the photobleached areas. (C) Protein dynamics derived from FRAP curves. The percentage of fluores-
cence recovery after 20 min, and the number of FRAP curves used are indicated.
Prebleach 0.5 s 5 min 20 min
GFP-SUV420H2
Protein Fluorescence Recovery after 
20 min (%)
# cells 
GFP-SUV420H2 22.6 % ± 3.0 14
GFP-H2AFY 7.8% ± 1.9 8
GFP-H2AFY
GFP-H2AFY
GFP HoechstBMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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(Pierce). Gel was sliced into 37 bands across the entire
separation range of the lane. Cut bands were reduced,
alkylated with iodoacetamide, and in-gel digested with
trypsin (Promega) as described previously [35]. In brief,
gel bands were destained overnight at 4°C in a solution
containing 50 mM NH4HCO3 and 50% acetonitrile, dehy-
drated in acetonitrile, and dried in a vacuum centrifuge.
Gel pieces were then rehydrated at 4°C for 45 min in a
digestion buffer (25 mM NH4HCO3  and 12.5 ng/μl
trypsin). The supernatant was replaced by 50 μl of 25 mM
NH4HCO3, and the samples were incubated overnight at
37°C. The tryptic peptides were recovered by 10-min
incubations, twice in 45% acetonitrile, 10% HCOOH and
once in 95% acetonitrile, 5% HCOOH. All supernatants
were pooled and dried in a vacuum centrifuge.
Each tryptic digest sample was subjected to nano-LC-
nano-ESI-MS/MS analysis on an ion trap mass spectrome-
ter (LCQ Deca XP+, Thermo Electron Corp.), equipped
with a nanoelectrospray ion source, coupled with a nano-
high pressure liquid chromatography system (LC Pack-
ings Dionex). Samples were resuspended in 3 μl of 0.1%
HCOOH, and 1.4 μl were injected into the mass spec-
trometer using a Famos autosampler (LC Packings
Dionex). The samples were first desalted and then concen-
trated on a reverse phase precolumn of 5 mm × 0.3 mm
inner diameter (Dionex) by solvent A (95% H2O, 5% ace-
tonitrile, 0.1% HCOOH) delivered by the Switchos
pumping device (LC Packings Dionex) at a flow rate of 10
μl/min for 3 min. Peptides were separated on a 15 cm ×
75 μm-inner diameter C18 PepMap column (Dionex).
The flow rate was set at 200 nl/min. Peptides were eluted
using a 5–70% linear gradient of solvent B (20% H2O,
80% acetonitrile, 0.08% HCOOH) in 45 min. Coated
nanoelectrospray needles (360 μm outer diameter, 20 μm
inner diameter, 10 μm tip inner diameter, standard coat-
ing) were obtained from New Objective (Woburn, MA).
Spray voltage was set at 1.5 kV, and capillary temperature
was set at 170°C. The mass spectrometer was operated in
positive ionization mode.
Data acquisition was performed in a data-dependent
mode consisting of, alternatively in a single run, a full-
scan MS over the range m/z 500–2,000 and a full MS/MS
of the ion selected in an exclusion dynamic mode (the
most intense ion is selected and excluded for further selec-
tion for a duration of 3 min). MS/MS data were acquired
using a 2 m/z unit ion isolation window and 35% relative
collision energy. MS/MS .raw data files were transformed
to .dta files with the Bioworks 3.1 software (Thermo Elec-
tron Corp.). The .dta files generated were next concate-
nated with merge.bat (a DOS batch file for Windows) to
be uploaded in Mascot public interface version 2.2.03
http://www.matrixscience.com for database searches in
Swiss-Prot 55.1 (359,942 sequences; 129,199,355 resi-
dues).
Search parameters in human sequences were: three
allowed missed cleavages, methionine oxidation and
cysteine carbamidomethylation as variable modifications,
2 Da for peptide tolerance, and 0.8 Da for MS/MS toler-
ance. Results were scored using the probability-based
Mowse score [the protein score is -10 × log(p), where p is
the probability that the observed match is a random
event]. Most proteins were unambiguously identified by
the sequencing of several independent peptides. Identifi-
cations with Mascot individual ion score < 38 or with the
significance threshold p > 5% (indicate identity or exten-
sive homology) were categorically rejected. In addition,
because a shared sequence may represent a problem, for
single peptide identifications, all sequences obtained by
MS/MS analysis were checked using the Basic Local Align-
ment Search Tool (BLAST) public interface (version
2.2.18) to exclude that sequence sharing with other pro-
teins could interfere with the reliability of the identifica-
tion.
In vitro GST protein binding assays
GST fusion proteins, were expressed in E. coli BL21 (DE3)
and purified on glutathione-Sepharose 4B (GE Health-
care) according to the manufacturer's instructions. GST-
proteins were then fixed on glutathione-Sepharose 4B and
stored in STE buffer (10 mM Tris-HCl pH8, 150 mM
NaCl, 1 mM EDTA and complete protease inhibitors
[Roche]). After preclearing with empty beads, nuclear
extracts (~500 μg proteins) were incubated with immobi-
lized GST-fusion proteins overnight at 4°C. Beads were
washed four times with E1A Buffer (50 mM Hepes, pH
7.9, 1 mM EGTA, 250 mM NaCl, 1 mM DTT, 1 mM EDTA
and complete protease inhibitors [Roche]) and bound
proteins were recovered with the Elution Buffer (10 mM
glutathione in 50 mM Tris-HCl pH 8.0), resolved by 4–
12% gradient SDS-PAGE (Invitrogen) and visualized by
Western blotting using the peroxidase-anti-peroxidase
(PAP) antibody (Sigma) which recognizes the protein A
moiety of the TAP tag. Input material corresponds to 2%
of the material used in the binding assays.
Nuclear extracts used for GST-pull downs were prepared
from HEK293 cells transiently expressing TAP-tagged pro-
teins. Forty eight hours after transfection, cells were lysed
in low salt buffer (10 mM Tris-HCl pH 7.4, 25 mM NaCl,
2 mM MgOAc, 1 mM DTT, 1 mM EDTA, 0.05% NP-40
and complete protease inhibitors [Roche]) for 15 min at
4°C. Nuclei were pelleted by centrifugation at 4°C for 10
min at 800 g, and lysed in E1A buffer during 2 hours by
gently shaking at 4°C. Nuclear proteins were recovered by
centrifugation at 2500 g, 10 min at 4°C.BMC Cell Biology 2009, 10:41 http://www.biomedcentral.com/1471-2121/10/41
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In vitro translated proteins used for GST-pull downs were
produced with the TnT7 Quick Coupled Transcription/
Translation System (Promega). Immobilized GST-fusion
proteins were incubated with in vitro translated proteins
overnight at 4°C in IP buffer (50 mM Tris-HCl pH7.5, 500
mM NaCl, 1 mM EDTA, 0.5% NP-40, 10% glycerol and
complete protease inhibitors [Roche]). The beads were
washed four times with IP buffer and resuspended in
loading buffer. Bound proteins were resolved by SDS-
PAGE and visualized by Western blotting.
Fluorescence recovery after photobleaching
FRAP experiments were performed in living cells and
dynamic parameters determined according to McNally
[36]. Briefly, GFP-expressing L929 cells were plated on
coverslip surfaces, grown in L15 medium (Invitrogen),
and maintained at 37°C in a Leica live-cell chamber. A
Leica SP2 confocal microscope equipped with an oil 100×
NA 1.4 plan Apo lens objective, a 488 nm mono-ray laser
line, and a linear regime detector in intensity measure-
ments were used for FRAP experiments [37]. Five pre-
bleach acquisitions were performed to measure back-
ground, fluorescence fading, and pre-bleach fluorescence
intensity. The laser power was calibrated using an acou-
sto-optical tunable filter (AOTF). Pre-bleach and post-
bleach imaging were performed with an AOTF setting at
5% (5 mW), whereas photobleaching was at 100% AOTF
(100 mW). The bleached area was chosen circular for sim-
plicity of the equations available to analyze fluorescence
recovery for such a shape [38]. The bleached regions had
a size of 1 to 1.3 μm of diameter, and were subjected to
five excitation pulses of 336 ms each at high laser power.
Post-bleach images were collected at 20 time intervals of
336 ms, 15 time intervals of 1,336 s and 15 time intervals
of 2,336 s.
Relative fluorescence intensities within the bleached area
were plotted as a function of time, yielding the RAW FRAP
curve. The recovery curves were corrected for background,
fluorescence fading, and decrease in fluorescence during
photobleaching. The t1/2 value was defined as the time
required for reaching half-maximum recovery and was
calculated from the corrected recovery curves obtained
using an in-house modified MATLAB fitting tool (Math-
works) using fit curves where the intensity recovered in
time follows the exponential law,
according to McNally and colleagues [36,39].
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